Walsh & Hoyt: Treatment and Prognosis

Update Item Information
Identifier wh_ch60_p3506_2
Title Walsh & Hoyt: Treatment and Prognosis
Creator Laura J. Balcer, MD
Affiliation Professor, Department of Neurology, NYU Langone
Subject Demyelinating Diseases; Myelinoclastic Diffuse Sclerosis; Encephalitis Periaxialis Diffusa; Schilder's Disease; Treatment; Prognosis
Description Most patients with myelinoclastic diffuse sclerosis follow a progressive unremitting course that ends in death within a few months or years; however, some patients experience spontaneous temporary or permanent improvement, and rare patients survive for a decade or longer. Patients may also improve after being treated with systemic corticosteroids administered orally, IV, or both. The patient reported by Lana-Peixoto and dos Santos experienced improvement in vision from hand motions in each eye to 20/20. Konkol et al. reported improvement in an 8-year-old boy after IV administration of adrenocorticotropic hormone and cyclophosphamide. Patientswho improve clinically generally show disappearance or shrinkage of the lesions seen on neuroimaging studies. Neurosurgical resection also has a role in treatment, and IV-Ig was used successfully in one case series.
Date 2005
Language eng
Format application/pdf
Type Text
Relation is Part of Walsh and Hoyt's Clinical Neuro-Ophthalmology Walsh and Hoyt's Clinical Neuro-Ophthalmology
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Wolters Kluwer Health, Philadelphia
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-5890
Rights Management Copyright 2005. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6pz8jbh
Setname ehsl_novel_whts
ID 186729
Reference URL https://collections.lib.utah.edu/ark:/87278/s6pz8jbh
Back to Search Results